Efficacy and Safety Study of ELIGARD 22.5mg With Prostate Cancer

Press/Media: Press / Media

Period2018 Oct 2

Media coverage

1

Media coverage

  • TitleEfficacy and Safety Study of ELIGARD 22.5mg With Prostate Cancer
    Media name/outletClinical Trials.gov
    CountryUnited States
    Date18/10/2
    PersonsByungha Chung